Evidence map›Paper›PMID 26092974›Full record

ArticleSexually transmitted infections2016

Medicated sex in Britain: evidence from the third National Survey of Sexual Attitudes and Lifestyles.

Kirstin R Mitchell, Philip Prah, Catherine H Mercer, Jessica Datta, Clare Tanton, Wendy Macdowall, Andrew J Copas, Soazig Clifton, Pam Sonnenberg, Nigel Field and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Sexually transmitted infections, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Kirstin R MitchellDepartment of Social and Environmental Health Research, London School of Hygiene and Tropical Medicine, London, UK.
Philip PrahResearch Department of Infection and Population Health, University College London, London, UK.
Catherine H MercerResearch Department of Infection and Population Health, University College London, London, UK.
Jessica DattaDepartment of Social and Environmental Health Research, London School of Hygiene and Tropical Medicine, London, UK.
Clare TantonResearch Department of Infection and Population Health, University College London, London, UK.
Wendy MacdowallDepartment of Social and Environmental Health Research, London School of Hygiene and Tropical Medicine, London, UK.
Andrew J CopasResearch Department of Infection and Population Health, University College London, London, UK.
Soazig CliftonResearch Department of Infection and Population Health, University College London, London, UK.
Pam SonnenbergResearch Department of Infection and Population Health, University College London, London, UK.
Nigel FieldResearch Department of Infection and Population Health, University College London, London, UK.
Anne M JohnsonResearch Department of Infection and Population Health, University College London, London, UK.
Kaye WellingsDepartment of Social and Environmental Health Research, London School of Hygiene and Tropical Medicine, London, UK.

Funding

Medical Research Council G0701757Wellcome Trust
6 · The paper itself

Abstract

objectivesTo describe the prevalence of medication use to assist sexual performance in Britain and to identify associated factors.

methodsCross-sectional probability sample, undertaken in 2010-2012, of 15 162 people aged 16-74 years, resident in Britain, of whom, 5617 men and 8095 women reported sexual experience (ever) and 4817 men were sexually-active (reported sex in the last year).

resultsEver use of medication to assist sexual performance (medicated sex) was more commonly reported by men than women (12.9% (95% CI 11.9% to 13.9%) vs 1.9% (95% CI 1.7% to 2.3%)) and associated with older age in men and younger age in women. It was associated with reporting smoking, and use of alcohol and recreational drugs, as well as unsafe sex (≥2 partners and no condom use in the last year) in both men and women. Among men, the proportion reporting medicated sex in the last year was higher among those reporting erectile difficulties (ED) than those not doing so (28.4% (95% CI 24.4% to 32.8%) vs 4.1% (95% CI 3.4% to 4.9%)). In all men, medicated sex was associated with more frequent sexual activity, meeting a partner on the internet, unsafe sex and recent sexually transmitted infections diagnosis; associations that persisted after adjusting for same-sex behaviour and ED. However, there were significant interactions with reporting ED, indicating that among men with ED, medicated sex is not associated with same-sex behaviour and ever use of recreational drugs.

conclusionsA substantial minority of people in Britain report medicated sex, and the association between medicated sex and risky sexual behaviour is not confined to high-risk groups.

Indexed as

AdolescentAdultCross-Sectional StudiesFemaleHealth Knowledge, Attitudes, PracticeHealth SurveysHumansMaleMethamphetamineMiddle AgedPhosphodiesterase 5 InhibitorsPrevalenceRisk-TakingSexual BehaviorSexually Transmitted DiseasesSexual PartnersMethamphetaminePhosphodiesterase 5 InhibitorsSildenafil CitrateTestosteroneEPIDEMIOLOGY (GENERAL)ERECTILE DYSFUNCTIONSEXUAL BEHAVIOURSEXUAL DYSFUNCTION

Identifiers

PMID26092974
PMCPMC4752628

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.